Canagliflozin Alters the Gut, Oral, and Ocular Surface Microbiota of Patients with Type 2 diabetes mellitus
Cana proves to effectively improve the dysregulated glucose metabolism in patients with T2DM. This improvement is potentially attributed to the restoration of balance within the gut, oral, and ocular surface microbial communities.